Opus Genetics, Inc. Common Stock IRD
$3.54
+2.46%
at last close
Analyst Consensus
- Consensus Rating
- Buy (14 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $13.00
- Implied Upside
- +266.7%
- Price Target Range
- $7.00 – $20.00
- Analysts (12 mo)
- 14
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-22 | Chardan CapitalAndreas Argyrides |
Maintains | Buy | $16 |
| 2026-10-16 | CitizensJonathan Wolleben |
Reiterates | Market outperform | $17 |
| 2026-10-06 | Jones Trading |
Maintains | Buy | $10 → $17 |
| 2026-10-02 | Chardan CapitalAndreas Argyrides |
Maintains | Buy | $16 |
| 2026-09-10 | WedbushYun Zhong |
Maintains | Outperform | $10 → $13 |
| 2026-09-09 | OppenheimerAndreas Argyrides |
Maintains | Outperform | $10 → $20 |
| 2026-09-09 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $8 |
| 2026-09-09 | BTIGThomas Shrader |
Reiterates | Buy | $12 |
| 2026-09-09 | Chardan CapitalAndreas Argyrides |
Maintains | Buy | $13 |
| 2026-08-07 | RBC CapitalLisa Walter |
Maintains | Outperform | $10 → $9 |
| 2026-07-29 | TD CowenRitu Baral |
Initiates coverage on | Buy | — |
| 2026-07-06 | Chardan CapitalAndreas Argyrides |
Maintains | Buy | $13 |
| 2026-07-06 | BTIGThomas Shrader |
Reiterates | Buy | $12 |
| 2026-06-18 | Chardan CapitalAndreas Argyrides |
Maintains | Buy | $11 → $13 |
| 2026-06-17 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $8 |
| 2026-06-16 | BTIGThomas Shrader |
Reiterates | Buy | $12 |
| 2026-06-15 | CitizensJonathan Wolleben |
Reiterates | Market outperform | $11 |
| 2026-06-04 | GuggenheimDebjit Chattopadhyay |
Initiates coverage on | Buy | $16 |
| 2026-05-21 | Leerink PartnersLili Nsongo |
Initiates coverage on | Outperform | $10 |
| 2026-05-13 | CitizensJonathan Wolleben |
Maintains | Market outperform | $12 → $11 |
| 2026-04-28 | CitizensJonathan Wolleben |
Initiates coverage on | Market outperform | $12 |
| 2026-03-30 | Cantor FitzgeraldSteve Seedhouse |
Initiates coverage on | Overweight | $15 |
| 2026-03-16 | OppenheimerAndreas Argyrides |
Initiates coverage on | Outperform | $10 |
| 2026-03-12 | WedbushYun Zhong |
Maintains | Outperform | $8 → $10 |
| 2026-03-12 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $9 → $11 |
| 2026-03-02 | BTIGThomas Shrader |
Maintains | Buy | $7 → $12 |
| 2026-01-28 | BTIGThomas Shrader |
Reiterates | Buy | $7 |
| 2026-01-20 | BTIGThomas Shrader |
Initiates coverage on | Buy | $7 |
| 2025-12-10 | B. Riley SecuritiesMayank Mamtani |
Initiates coverage on | Buy | $9 |
| 2025-11-25 | Piper SandlerBiren Amin |
Initiates coverage on | Overweight | $7 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $3.54
- Market Cap
- $287.86 million
- 52-Week Range
- $1.50 – $7.07
- Average Volume
- 1.80 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.